®
Blood sampling method Less expensive and no painful procedures Patent pending with 3 biomarkers and an algorithm to generate results in 4 different stages Validated with 500+ samples
Hepatitis B Hepatitis C Alcoholic Liver Disease Metabolic / Non-Alcoholic Fatty Liver Disease
BioFibroScore ® platform shows an excellent accuracy (>0.95) in all stages, especially in early stages. The technology has been offered as a service bundling as Liver20 TM.
AUROC BioFibroScore ®
FIBROSIS STAGES F≥1
F≥2
F≥3
F≥4
>0.95
>0.95
>0.95
>0.95
ELISA Kits & Instruments, RT-PCR & instruments, Raw Materials, Labware, & CLIA (new) A No.6, Innovation First Road, Hsinchu Science Park, Taiwan, R.O.C. E sales.group@gbc.com.tw
T +886 3 577 9221
F +886 3 577 9227
www.gbc.com.tw